AD changes include the pathological accumulation of amyloid-beta plaques, tau neurofibrillary tangles, and neurodegeneration, including brain atrophy and network dysfunction (Serrano-Pozo et al., 2011). The gene discussed is MAPT; the disease is Alzheimer disease.